SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-304334
Filing Date
2018-10-22
Accepted
2018-10-22 17:18:51
Documents
7
Effectiveness Date
2018-10-22

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d637402ds8.htm S-8 61800
2 EX-5.1 d637402dex51.htm EX-5.1 7743
3 EX-10.1 d637402dex101.htm EX-10.1 146343
4 EX-10.2 d637402dex102.htm EX-10.2 344837
5 EX-10.3 d637402dex103.htm EX-10.3 60523
6 EX-23.1 d637402dex231.htm EX-23.1 1812
7 GRAPHIC g637402g11p82.jpg GRAPHIC 3028
  Complete submission text file 0001193125-18-304334.txt   628590
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-227935 | Film No.: 181132830
SIC: 2834 Pharmaceutical Preparations